Cardax, Inc.
CDXIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$80
P/E Ratio—
52W High$0.004
52W Low$0.000001
Cardax, Inc. (CDXI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CDXI · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2020-12 | 2019-12 | 2018-12 | 2017-12 | 2016-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.54M | $0.71M | $1.51M | $0.61M | $0.04M |
| Cost of Revenue | $0.20M | $0.35M | $0.70M | $0.27M | $0.01M |
| Gross Profit | $0.34M | $0.37M | $0.81M | $0.34M | $0.02M |
| Gross Margin %(computed) | 63.61% | 51.42% | 53.68% | 54.99% | 58.65% |
| Operating Expenses | |||||
| R&D Expenses | $0.14M | $0.32M | $0.27M | $0.46M | $0.35M |
| G&A Expenses | $3.23M | $4.09M | $4.53M | $1.31M | $1.36M |
| Total Operating Expenses | $3.41M | $4.44M | $4.83M | $2.34M | $1.85M |
| Operating Income | ($3.06M) | ($4.08M) | ($4.02M) | ($2.00M) | ($1.83M) |
| Operating Margin %(computed) | -568.26% | -573.47% | -266.24% | -328.07% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $2.38M | $0.62M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($5.06M) | ($5.09M) | ($4.02M) | ($1.99M) | ($1.78M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($5.06M) | ($5.09M) | ($4.02M) | ($1.99M) | ($1.78M) |
| Net Margin %(computed) | -938.04% | -716.37% | -266.35% | -325.28% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-6.79 | $-8.40 | $-6.32 | $-3.97 | $-4.68 |
| Wtd Avg Shares | 0.74M | 0.68M | 0.64M | 0.50M | 0.38M |
| EBITDA | ($2.64M) | ($4.43M) | ($3.99M) | ($1.97M) | ($1.75M) |
| EBITDA Margin %(computed) | -489.17% | -623.12% | -264.33% | -323.28% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Cardax, Inc. data
About Cardax, Inc. (CDXI) Income Statement
Cardax, Inc. (CDXI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2020, CDXI reported revenue of $0.00B, gross profit of $0.00B (gross margin 63.61%), and net income of ($0.01B) — a net profit margin of -938.04%.
Frequently asked questions
CDXI · 4 questionsCardax, Inc. (CDXI) reported revenue of $0.00B for 2020, down 24.2% year-over-year.
CDXI revenueCDXI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09